BioCorRx (BICX) Current Deferred Revenue (2010 - 2026)

BioCorRx (BICX) posted Current Deferred Revenue of $56590.0 for Q3 2025, little changed sequentially from $56590.0 in Q2 2025.

Analysis

BioCorRx (BICX) Current Deferred Revenue (2010 - 2026) Analysis & Trends

BioCorRx has reported Current Deferred Revenue for 16 years, with the latest figure at $56590.0 in Q3 2025.

Quarterly Current Deferred Revenue changed N/A year-over-year to $56590.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $56590.0 (changed N/A YoY) and the FY2024 annual result came in at $56590.0, up 1299.01% from the prior year.
Current Deferred Revenue was little changed at $56590.0 in Q3 2025 per BICX's latest filing, from $56590.0 in the prior quarter.
Over five years, Current Deferred Revenue peaked at $81099.0 in Q3 2021 and troughed at $4045.0 in Q1 2023.
A 5-year average of $36161.4 and a median of $34981.0 in 2021 frame the typical range for Current Deferred Revenue.
The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue sank 91.23% in 2023, then soared 1299.01% in 2024.
Over 5 years, Current Deferred Revenue stood at $72282.0 in 2021, then sank by 48.4% to $37301.0 in 2022, then plunged by 89.16% to $4045.0 in 2023, then jumped by 1299.01% to $56590.0 in 2024, then changed by 0.0% to $56590.0 in 2025.
According to Business Quant data, Current Deferred Revenue over the past three periods registered $56590.0, $56590.0, and $56590.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	90.36 Bn	89.35 Bn	15.19 Bn
2	Tenet Healthcare	22.02 Bn	19.85 Bn	4.45 Bn
3	Encompass Health	12.13 Bn	11.99 Bn	1.34 Bn
4	Davita	11.78 Bn	11.09 Bn	1.16 Bn
5	Universal Health Services	10.09 Bn	9.95 Bn	3.29 Bn
6	Ensign	9.97 Bn	9.65 Bn	306.24 Mn
7	Chemed	6.93 Bn	6.89 Bn	221.47 Mn
8	Pacs	6.81 Bn	6.64 Bn	338.46 Mn
9	Concentra Group Holdings Parent	4.32 Bn	4.16 Bn	192.10 Mn
10	BioCorRx	3.46 Mn	3.44 Mn	-

Historic Data

Download Data